NCT01782651
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Debrecen, Hungary
Clinical trial condition
Neoplasms, Breast
Explore clinical trials studying Neoplasms, Breast. Study availability and eligibility vary by location and protocol.
51 public trials
1 recruiting study
Neoplasms, Breast trial results
NCT02063893
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- Biological treatment center in Fuda cancer hospital Guangzhou, Guangdong, China
NCT00075270
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Hot Springs, Arkansas, United States
- GSK Investigational Site Jonesboro, Arkansas, United States
- GSK Investigational Site Fountain Valley, California, United States
NCT00062686
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Buenos Aires, Argentina
- GSK Investigational Site Villejuif, France
- GSK Investigational Site Augsburg, Bavaria, Germany
- GSK Investigational Site Sutton, Surrey, United Kingdom
NCT00051103
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +5 more
- Locations
-
- GSK Investigational Site Chula Vista, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Poway, California, United States
- GSK Investigational Site Fort Myers, Florida, United States
NCT01138046
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Aichi, Japan
- GSK Investigational Site Ehime, Japan
- GSK Investigational Site Hyōgo, Japan
- GSK Investigational Site Kagoshima, Japan
NCT00374322
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Tuscaloosa, Alabama, United States
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Sedona, Arizona, United States
- GSK Investigational Site Tucson, Arizona, United States
NCT00356811
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Liepāja, Latvia
- GSK Investigational Site Riga, Latvia
- GSK Investigational Site Riga, Latvia
- GSK Investigational Site Krakow, Poland
NCT00849472
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +4 more
- Locations
-
- GSK Investigational Site Decatur, Alabama, United States
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Huntsville, Alabama, United States
- GSK Investigational Site Antioch, California, United States
Completed
Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Inflammatory Breast Cancer
NCT00558103
- Conditions
- Breast Diseases, Breast Neoplasms, Inflammatory Breast Neoplasms, +5 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Sacramento, California, United States
- GSK Investigational Site Denver, Colorado, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States